Experimental ID SRX150471
Genome assembly hg19
Antigen class TFs and others
Antigen ATF3
Cell type class Blood
Cell type K-562
Cell type description Primary Tissue=Blood|Tissue Diagnosis=Leukemia Chronic Myelogenous
Processing logs 34337514, 69.2, 8.6, 1665
Title GSM935391: Harvard ChipSeq K562 ATF3 std
Meta data source_name=K562 || biomaterial_provider=ATCC || lab=Harvard || lab description=Struhl - Harvard University || datatype=ChipSeq || datatype description=Chromatin IP Sequencing || cell=K562 || cell organism=human || cell description=leukemia, "The continuous cell line K-562 was established by Lozzio and Lozzio from the pleural effusion of a 53-year-old female with chronic myelogenous leukemia in terminal blast crises." - ATCC || cell karyotype=cancer || cell lineage=mesoderm || cell sex=F || treatment=None || treatment description=No special treatment or protocol applies || antibody=ATF3 || antibody antibodydescription=Rabbit polyclonal IgG, epitope mapping at the C-terminus of ATF3 of human origin. Antibody Target: ATF3 || antibody targetdescription=Activating transcription factor 3. A bZIP transcription factor and member of the Ca2+/cAMP response element-binding (CREB) protein family. ATF3 is found to act both as an activator and repressor of transcription. || antibody vendorname=Santa Cruz Biotech || antibody vendorid=sc-188 || control=std || control description=Standard input signal for most experiments. || control=std || control description=Standard input signal for most experiments. || controlid=wgEncodeEH000615 || replicate=1
Peak-call (BED) (q < 1E-05) SRX150471.05.bed
Peak-call (BED) (q < 1E-10) SRX150471.10.bed
Peak-call (BED) (q < 1E-20) SRX150471.20.bed
Peak-call (BigBed) (q < 1E-05)
Peak-call (BigBed) (q < 1E-10)
Peak-call (BigBed) (q < 1E-20)